RCT | Effect of pentaerythritol tetranitrate (PETN) in pregnancies with impaired uteroplacental perfusion at midgestation.

Effect of pentaerythritol tetranitrate (PETN) on the development of fetal growth restriction in pregnancies with impaired uteroplacental perfusion at midgestation—a randomized trial – American Journal of Obstetrics & Gynecology

Commentary on Twitter

Effect of Pentaerythrityltetranitrate (PETN) on the development of fetal growth restriction in pregnancies with impaired uteroplacental perfusion at mid gestation – a randomised trial https://t.co/FJ3B7xV4sA pic.twitter.com/t32ij2Tssw

— AJOG (@AJOG_thegray) August 3, 2022